保留射精功能的中叶电切与汽化术:12年经验
该研究报告了仅切除前列腺中叶的经尿道前列腺电切术(MLO-TURP)的长期安全性和有效性。312名男性接受MLO-TURP,平均年龄61.3±8.6岁,平均前列腺体积79.8 g。结果显示症状评分、生活质量、最大尿流率和残余尿量持续改善,射精功能障碍发生率为2.6%,仅1例新发勃起功能障碍。
要点
- MLO-TURP可持久改善下尿路症状和生活质量。
- 术后射精功能障碍发生率低(2.6%),保留顺行射精。
- 对于中叶突出的患者,MLO-TURP是保留射精功能的治疗选择。
核心结论
- MLO-TURP是治疗男性下尿路症状安全有效的方法,可长期改善症状并保留顺行射精。
研究设计与样本
- 回顾性分析2005年至2017年接受MLO-TURP的312例男性,平均年龄61.3±8.6岁。
- 评估指标包括国际前列腺症状评分、生活质量、最大尿流率、残余尿量、国际勃起功能指数和射精功能。
主要发现
- 国际前列腺症状评分、生活质量、最大尿流率和残余尿量在整个研究期间持续改善。
- 单极和双极MLO-TURP的结果无差异。
- 术后射精功能障碍发生率为2.6%(8例),新发勃起功能障碍1例(0.3%)。
- 射精功能困扰评分从基线2.4改善至5年时1.27。
关键数值与推荐
- 平均基线前列腺体积79.8 g(范围30-178 g),平均基线膀胱内前列腺突出13.6。
- 射精功能障碍发生率2.6%,新发勃起功能障碍发生率0.3%。
临床怎么用
- 对于中叶突出的下尿路症状患者,可考虑MLO-TURP作为保留射精功能的治疗选项。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report long-term safety and efficacy data on middle lobe only-transurethral resection of the prostate (TURP) (MLO-TURP). MATERIALS AND METHODS: We evaluated: (1) efficacy: International Prostate Symptom Score, Quality of Life, peak flow rate (Qmax), postvoid residual urine, International Index of Erectile Function and ejaculatory function, which was assessed by the Male Sexual Health Questionnaire. Men were evaluated at 1 month, 6 months, and yearly thereafter. RESULTS: A total 312 men (mean age 61.3 ± 8.6) with significant lower urinary tract symptoms (n = 147) or urinary retention (n = 175 were treated with MLO-TURP from 2005 to 2017. Mean baseline prostate volume was 79.8 g (30-178 g); mean baseline intravesical-prostatic protrusion was 13.6. Improvements in International Prostate Symptom Score, Quality of Life, Qmax and postvoid residual urine were durable throughout the study period. There was no difference in outcomes between monopolar and bipolar MLO-TURPs. Postoperatively, the incidence of ejaculatory dysfunction was 2.6% (N = 8) and there was 1 case of new onset ED (0.3%). There were modest improvement in bother due to ejaculatory function (baseline: 2.4 and at 5 years: 1.27). CONCLUSION: MLO-TURP is a safe and effective treatment for men with lower urinary tract symptoms. Patients experience long-term improvement of symptoms and preserve antegrade ejaculation. In select men with prominent middle lobes, MLO-- should be considered a therapeutic, ejaculation-sparing option.
引用
- Gul Z, Chughtai B, Te AE, et al. Ejaculatory Preserving Middle Lobe Onl-Transurethral Resection and Vaporization of the Prostate: 12-Year Experience. Urology. 2019. PMID: 31563537. doi:10.1016/j.urology.2019.07.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。